AAPS PharmSciTech

, Volume 5, Issue 4, pp 84–91 | Cite as

Molecular properties of ciprofloxacin-indion 234 complexes

  • Sambhaji Pisal
  • Rana Zainnuddin
  • Pradeep Nalawade
  • Kakasaheb Mahadik
  • Shivajirao Kadam
Article

Abstract

The purpose of this research was to formulate tasteless complexes of ciprofloxacin with Indion 234 and to evaluate molecular properties of drug complexes. The effect of batch and column process, complexation time, temperature, and pH on ciprofloxacin loading on Indion 234 is reported. Drug resin complexes (DRC) were characterized by infrared spectroscopy, thermal analysis, and x-ray diffraction pattern. Ciprofloxacin release from DRC is obtained at salivary and gastric pH and in the presence of electrolytes. The efficient drug loading was evident in batch process using activated Indion 234 with a drug-resin ratio of 1∶1.3. Drug complexation enhanced with pH from 1.2 to 6, while temperature did not affect the complexation process. Infrared spectroscopy revealed complexation of—NH (drug) with Indion 234. DRC are amorphous in nature. Drug release from DRC in salivary pH was insufficient to impart bitter taste. Volunteers rated the complex as tasteless and agreeable. Complete drug release was observed at gastric pH in 2 hours. The drug release was accelerated in the presence of electrolytes. Indion 234 is inexpensive, and the simple technique is effective for bitterness masking of ciprofloxacin.

Keywords

ciprofloxacin Indion 234 tasteless complex characterization electrolyte release 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Glen M. Taste masking in oral pharmaceuticals.Pharm Technol. 1994; 18(4):84–98.Google Scholar
  2. 2.
    Aoi M, Murata A, inventors. Control of bitter taste of pharmaceuticals and food. Japanese patent 04346937. February 12, 1992.Google Scholar
  3. 3.
    Blase CM, Shah M, inventors. Taste masked pharmaceutical suspensions containing xanthum gum and microcrystalline cellulose. European patent 0556057. August 18, 1993.Google Scholar
  4. 4.
    Gowan WG, Bruce RD, inventors. Aliphatic or fatty acid as a solventless carriers for pharmaceuticals. US patent 5 405 617. April 11, 1995.Google Scholar
  5. 5.
    Kasturagi Y, Kurihari K. Specific inhibitors for bitter taste.Nature. 1993;(6443):213–214.Google Scholar
  6. 6.
    Motola S, Agisim G, inventors. Palatable ibuprofen solutions. US patent 5 024 997. June 18, 1991.Google Scholar
  7. 7.
    Robert R, Brown J. Solubility limiting methods. German patent office. 39214. March 25, 1990.Google Scholar
  8. 8.
    Deasy PB. Microencapsulation and related drug processes. In: Swarbrick J, Boylan JC, eds.Encyclopedia of Pharmaceutical Technology. New York, NY: Marcel Dekker, 1984:241–243.Google Scholar
  9. 9.
    Patricia K, Edward R, Joel S, Imtiaz C, inventors. Sustained release oral suspensions. US patent 4 999 189. March 12, 1991.Google Scholar
  10. 10.
    Betty W, Michael P, Dokuzovic V, Lam V. Antitussive drugs delivered by ion exchange resins. US patent 6 001 392. December 14, 1999.Google Scholar
  11. 11.
    Borodkin P, Sundberg PD. Polycarboxylic acid ion-exchange resin adsorbates for taste coverage in chewable tablets.J Pharm Sci. 1971;60:1523–1527.CrossRefGoogle Scholar
  12. 12.
    Maria CB, Silvia S, Franc F, Evy S, Angelina PR, Carla C. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes.AAPS Pharm Sci Tech. 2000;1:E15.CrossRefGoogle Scholar
  13. 13.
    Carola A, Maria CB, Maria R, Silvia S, Franaca F, Carla C. Influence of complex solubility on formulations based on lambda carrageenan and basic drugs.AAPS Pharm Sci Tech. 2002;3:E27.CrossRefGoogle Scholar
  14. 14.
    Akkaramonkolporn P, Katsuhide T. Molecular properties of propranolol hydrochloride prepared as drug-resin complexes.Drug Dev Ind Pharm. 2001;27:359–364.CrossRefGoogle Scholar
  15. 15.
    Raghunanthan Y, Amsel L, Hinsvark ON, Bryant WJ. Sustained-release drug delivery system. I: Coated ion-exchange resin system for phenylpropanolamine and other drugs.J Pharm Sci. 1981;70:379–383.CrossRefGoogle Scholar
  16. 16.
    Borodkin S. Ion exchange resin delivery systems. In: Tarcha PJ, ed.Polymers for Controlled Drug Delivery. Boca Raton, FL: CRC Press; 1991:215–230.Google Scholar
  17. 17.
    Borodkin S, Yunker MH. Interaction of amine drugs with a polycarboxylic acid ion-exchange resin.J Pharm Sci. 1970;59:481–486.CrossRefGoogle Scholar
  18. 18.
    Vaviya S, Bajaj A. Oral controlled release bromhexine ion exchange resinate suspension formulation.Ind Drugs. 2000;37:185–189.Google Scholar
  19. 19.
    Santos L, Ghaly ES. Design and development of suspension containing drug resin complex.AAPS Pharm Sci. 2003;5(S1):T3257.Google Scholar
  20. 20.
    Borodkin SS. Ion exchange resins and sustained release. In: Swarbrick J, Boylan JC, eds.Encyclopedia of Pharmaceutical Technology. New York, NY: Marcel Dekker, 1993:241–243.Google Scholar
  21. 21.
    Agarwal R, Mittal R. Studies on ion exchange resin complex of chloroquine phosphate.Drug Dev Ind Pharm. 2001;27:359–364.CrossRefGoogle Scholar
  22. 22.
    Glasstone S, Lewis D.Elements of Physical Chemistry. London, UK: Macmillan and Company, Ltd; 1960.Google Scholar
  23. 23.
    Frank D, Koebel B. Some like it hot, some like it cold.Water Quality. 2000;54:54–57.Google Scholar
  24. 24.
    Plazier VJA. Investigation of the bioavailability of codeine from a cation ion-exchange sulfonic acid. I. Effect of parameters.Int J Pharm. 1992;85:45–50.CrossRefGoogle Scholar
  25. 25.
    Silverstein RM, Bassler GC, Morrill TC. Infrared spectroscopy. In: Dennis S, ed.Spectroscopic Identification of Organic Compounds. Singapore: John Wiley; 1991:91–133.Google Scholar
  26. 26.
    Conaghey OM, Coris J, Corrigan OI. The release of nicotine from a hydrogel containing ion exchange resins.Int J Pharm. 1998;170:215–224.CrossRefGoogle Scholar
  27. 27.
    Jasari T, Vuorio M. Ion exchange fibers and drugs: an equilibrium study.J Control Release. 2001;70:219–229.CrossRefGoogle Scholar
  28. 28.
    Herrera T, Matejka Z, Eliasek J. Cation exchange kinetics on carboxylic acid resins in a multicomponent system H−Me+−Me2+.Desalination. 1983;48:161–169.CrossRefGoogle Scholar
  29. 29.
    Liu Z, Cheung R, Wu Yu X, James R. A study of doxorubicin loading onto and release from sulfopropyl dextran ion-exchange microspheres.J Control Release. 2001;77:213–224.CrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2004

Authors and Affiliations

  • Sambhaji Pisal
    • 1
  • Rana Zainnuddin
    • 1
  • Pradeep Nalawade
    • 1
  • Kakasaheb Mahadik
    • 1
  • Shivajirao Kadam
    • 1
  1. 1.Poona College of Pharmacy and Research CenterBharati Vidyapeeth Deemed UniversityPuneIndia

Personalised recommendations